Anti-LRC17/ LRRC17/ P37NB functional antibody

Anti-LRC17/ LRRC17/ P37NB functional antibody for cell culture, ELISA & in-vivo assay

Target products collectionGo to LRRC17/LRRC17 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-SE1082-Ab-1/ GM-Tg-hg-SE1082-Ab-2Anti-Human LRRC17 monoclonal antibodyHuman
GM-Tg-rg-SE1082-Ab-1/ GM-Tg-rg-SE1082-Ab-2Anti-Rat LRRC17 monoclonal antibodyRat
GM-Tg-mg-SE1082-Ab-1/ GM-Tg-mg-SE1082-Ab-2Anti-Mouse LRRC17 monoclonal antibodyMouse
GM-Tg-cynog-SE1082-Ab-1/ GM-Tg-cynog-SE1082-Ab-2Anti-Cynomolgus/ Rhesus macaque LRRC17 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-SE1082-Ab-1/ GM-Tg-felg-SE1082-Ab-2Anti-Feline LRRC17 monoclonal antibodyFeline
GM-Tg-cang-SE1082-Ab-1/ GM-Tg-cang-SE1082-Ab-2Anti-Canine LRRC17 monoclonal antibodyCanine
GM-Tg-bovg-SE1082-Ab-1/ GM-Tg-bovg-SE1082-Ab-2Anti-Bovine LRRC17 monoclonal antibodyBovine
GM-Tg-equg-SE1082-Ab-1/ GM-Tg-equg-SE1082-Ab-2Anti-Equine LRRC17 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-SE1082-Ab-1/ GM-Tg-hg-SE1082-Ab-2; GM-Tg-rg-SE1082-Ab-1/ GM-Tg-rg-SE1082-Ab-2;
GM-Tg-mg-SE1082-Ab-1/ GM-Tg-mg-SE1082-Ab-2; GM-Tg-cynog-SE1082-Ab-1/ GM-Tg-cynog-SE1082-Ab-2;
GM-Tg-felg-SE1082-Ab-1/ GM-Tg-felg-SE1082-Ab-2; GM-Tg-cang-SE1082-Ab-1/ GM-Tg-cang-SE1082-Ab-2;
GM-Tg-bovg-SE1082-Ab-1/ GM-Tg-bovg-SE1082-Ab-2; GM-Tg-equg-SE1082-Ab-1/ GM-Tg-equg-SE1082-Ab-2
Products NameAnti-LRRC17 monoclonal antibody
Formatmab
Target NameLRRC17
Protein Sub-locationSecreted Protein/Potential Cytokines
Category of antibodyFACS/Biofunctional Antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The biofunction of antibodies are validated with in-vitro assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-LRRC17 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-SE1082-Ag-1Recombinant multi-species LRC17/ LRRC17/ P37NB protein
    ORF Viral VectorpGMLP004770human LRRC17 Lentivirus plasmid
    ORF Viral VectorvGMLP004770human LRRC17 Lentivirus particle
    ORF Viral VectorpGMLV000803house mouse Lrrc17 Lentivirus plasmid
    ORF Viral VectorpGMLPm002945mouse Lrrc17 Lentivirus plasmid
    ORF Viral VectorvGMLV000803house mouse Lrrc17 Lentivirus particle
    ORF Viral VectorvGMLPm002945mouse Lrrc17 Lentivirus particle


    Target information

    Target IDGM-SE1082
    Target NameLRRC17
    Gene ID10234,74511,502715,695422,100685094,101087649,777690,100050177
    Gene Symbol and Synonyms37kDa,4833425M04Rik,6130400C22Rik,LRRC17,P37NB
    Uniprot AccessionQ8N6Y2
    Uniprot Entry NameLRC17_HUMAN
    Protein Sub-locationSecreted Protein/Potential Cytokines
    Category
    DiseaseN/A
    Gene EnsemblENSG00000128606
    Target ClassificationN/A

    The target: LRRC17, gene name: LRRC17, also named as P37NB. Predicted to be involved in bone marrow development and negative regulation of osteoclast differentiation. Predicted to be active in extracellular matrix and extracellular space. [provided by Alliance of Genome Resources, Apr 2022].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.